REST Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with REST Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with REST Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with REST Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with REST Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000085465 - oviductal glycoprotein 1

Gene

ENSG00000030066 - nucleoporin 160

Gene

ENSG00000100417 - phosphomannomutase 1

Gene

ENSG00000048649 - remodeling and spacing factor 1

Gene

ENSG00000132964 - cyclin dependent kinase 8

Gene

ENSG00000134343 - anoctamin 3

Gene

ENSG00000116698 - SMG7 nonsense mediated mRNA decay factor

Gene

ENSG00000104432 - interleukin 7

Gene

ENSG00000110429 - F-box protein 3

Gene

ENSG00000164253 - WD repeat domain 41

  • Gene

    ENSG00000085465 - oviductal glycoprotein 1


  • Gene

    ENSG00000030066 - nucleoporin 160


  • Gene

    ENSG00000100417 - phosphomannomutase 1


  • Gene

    ENSG00000048649 - remodeling and spacing factor 1


  • Gene

    ENSG00000132964 - cyclin dependent kinase 8


  • Gene

    ENSG00000134343 - anoctamin 3


  • Gene

    ENSG00000116698 - SMG7 nonsense mediated mRNA decay factor


  • Gene

    ENSG00000104432 - interleukin 7


  • Gene

    ENSG00000110429 - F-box protein 3


  • Gene

    ENSG00000164253 - WD repeat domain 41

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.